James B Galloway (James Galloway)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 57

Top Topics

Rheumatoid Arthritis

Top Venues

Rheumatology advances in practice

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Maryam Adas, Mrinalini Dey, Katherine Jones, Heidi Lempp, Maya H Buch, Andrew Cope, James B Galloway, Elena Nikiphorou
What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit. RMD open 10 (3) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology (2024)
Nkasi Stoll, Mrinalini Dey, Katherine Jones, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew Cope, Heidi Lempp, James B Galloway, Elena Nikiphorou
Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study. RMD open 10 (2) (2024)
Edward Alveyn, James B Galloway, Laura C Coates
Patient-Initiated Follow-Up. The Journal of rheumatology 51 (6) (2024)
Nkasi Stoll, Mrinalini Dey, Katherine Jones, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew Cope, Heidi Lempp, James B Galloway, Elena Nikiphorou
Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study. RMD open 10 (2) (2024)
Maryam Adas, Mrinalini Dey, Katherine Jones, Heidi Lempp, Maya H Buch, Andrew Cope, James B Galloway, Elena Nikiphorou
What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit. RMD open 10 (3) (2024)
Louise Mercer, Abhishek Abhishek, Akhila Kavirayani, Alison Ahmed, Alan Davidson, Amy Foulkes, Claire Jones, Clare Nash, Emily Rose-Parfitt, Emmandeep Dhillon, Genevieve Zabate, Helen Twohig, Hope De Vere, Jennifer Scott, John A Reynolds, Julia Holmes, Karen Hartley, Kishore Warrier, Katarzyna Nowak, Kate Parsons, Katie Bechman, Lisa Bray, Madura Adikari, Natasha Wood, Nicola Faithfull, Nicola J Gullick, Pratyasha Saha, Rebecca Heaton, Samundeeswari Deepak, Samantha L Hider, Sameena Khalid, Sanaa Suleiman Said, Sarah Ryan, Stuart Kyle, Subhra Raghuvanshi, Su-Yin Tan, Vinay Shivamurthy, James B Galloway
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope. Rheumatology advances in practice 8 (3) (2024)
Hema Chaplin, Carol Simpson, Kate Wilkins, Jessica Meehan, Nora Ng, James B Galloway, Ian C Scott, Debajit Sen, Rachel Tattersall, Rona Moss-Morris, Heidi Lempp, Katherine Jones
Management of refractory disease and persistent symptoms in inflammatory arthritis: qualitative framework analysis of interviews with patients and healthcare professionals. Rheumatology advances in practice 8 (3) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology 20 (2) (2024)
Hema Chaplin, Carol Simpson, Kate Wilkins, Jessica Meehan, Nora Ng, James B Galloway, Ian C Scott, Debajit Sen, Rachel Tattersall, Rona Moss-Morris, Heidi Lempp, Katherine Jones
Management of refractory disease and persistent symptoms in inflammatory arthritis: qualitative framework analysis of interviews with patients and healthcare professionals. Rheumatology advances in practice 8 (3) (2024)
Nkasi Stoll, Mrinalini Dey, Katherine Jones, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew Cope, Heidi Lempp, James B Galloway, Elena Nikiphorou
Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study. RMD open 10 (2) (2024)
Nkasi Stoll, Mrinalini Dey, Katherine Jones, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew Cope, Heidi Lempp, James B Galloway, Elena Nikiphorou
Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study. RMD open 10 (2) (2024)
Louise Mercer, Abhishek Abhishek, Akhila Kavirayani, Alison Ahmed, Alan Davidson, Amy Foulkes, Claire Jones, Clare Nash, Emily Rose-Parfitt, Emmandeep Dhillon, Genevieve Zabate, Helen Twohig, Hope De Vere, Jennifer Scott, John A Reynolds, Julia Holmes, Karen Hartley, Kishore Warrier, Katarzyna Nowak, Kate Parsons, Katie Bechman, Lisa Bray, Madura Adikari, Natasha Wood, Nicola Faithfull, Nicola J Gullick, Pratyasha Saha, Rebecca Heaton, Samundeeswari Deepak, Samantha L Hider, Sameena Khalid, Sanaa Suleiman Said, Sarah Ryan, Stuart Kyle, Subhra Raghuvanshi, Su-Yin Tan, Vinay Shivamurthy, James B Galloway
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope. Rheumatology advances in practice 8 (3) (2024)
Maryam Adas, Mrinalini Dey, Katherine Jones, Heidi Lempp, Maya H Buch, Andrew Cope, James B Galloway, Elena Nikiphorou
What role do socioeconomic and clinical factors play in disease activity states in rheumatoid arthritis? Data from a large UK early inflammatory arthritis audit. RMD open 10 (3) (2024)
Edward Alveyn, James B Galloway, Laura C Coates
Patient-Initiated Follow-Up. The Journal of rheumatology 51 (6) (2024)
Zijing Yang, Nikita Arumalla, Edward Alveyn, Sarah Gallagher, Elizabeth Price, Mark D Russell, Katie Bechman, Katherine Jones, James B Galloway
Trust performance in managing inflammatory arthritis over time in England and Wales: a latent class analysis approach. Rheumatology advances in practice 8 (2) (2024)
Zijing Yang, Nikita Arumalla, Edward Alveyn, Sarah Gallagher, Elizabeth Price, Mark D Russell, Katie Bechman, Katherine Jones, James B Galloway
Trust performance in managing inflammatory arthritis over time in England and Wales: a latent class analysis approach. Rheumatology advances in practice 8 (2) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology 20 (2) (2024)
Yinghua Zhao, James B Galloway, Jo Ledingham, Sarah Gallagher, Gerasimina Garnavos, Paul Amlani-Hatcher, Nicky Wilson, Lewis Carpenter, Kirsty Bannister, Katherine Jones
Psychological distress over 12 months post-diagnosis in an early inflammatory arthritis cohort. Rheumatology (Oxford, England) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology 20 (2) (2024)
Edward Alveyn, James B Galloway, Laura C Coates
Patient-Initiated Follow-Up. The Journal of rheumatology (2024)
Nkasi Stoll, Mrinalini Dey, Katherine Jones, Maryam Adas, Ailsa Bosworth, Maya H Buch, Andrew Cope, Heidi Lempp, James B Galloway, Elena Nikiphorou
Understanding the psychosocial determinants of effective disease management in rheumatoid arthritis to prevent persistently active disease: a qualitative study. RMD open 10 (2) (2024)
Melissa Sweeney, Lewis Carpenter, Savia de Souza, Hema Chaplin, Hsiu Tung, Emma Caton, James B Galloway, Andrew P Cope, Mark Yates, Elena Nikiphorou, Katherine Jones
Ongoing shielding behavior one year post COVID-19: results from a longitudinal study of patients with inflammatory arthritis. Rheumatology international (2023)
James A Prior, Edward Roddy, Ivonne Solis-Trapala, Nicola Cornwall, Clare Jinks, Abhishek Abhishek, Marwan Bukhari, James B Galloway, Nicola Goodson, Sue Jowett, Samantha L Hider
How do clinicians prescribe bridging glucocorticoids in people starting or escalating disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a service evaluation survey. Rheumatology advances in practice 7 (3) (2023)
Fabiola Atzeni, Francesco Gozza, Agostino Riva, Alessandra Alciati, James B Galloway
Conventional, biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors and varicella zoster virus. Expert opinion on pharmacotherapy (2023)
Alejandro Balsa, Siegfried Wassenberg, Yoshiya Tanaka, Anne Tournadre, Hans-Dieter Orzechowski, Vijay Rajendran, Udo Lendl, Pieter-Jan Stiers, Chris Watson, Roberto Caporali, James B Galloway, Patrick Verschueren
Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid Arthritis. Rheumatology and therapy (2023)
Mark D Russell, Christopher Stovin, Edward Alveyn, Olukemi Adeyemi, Chun Kit David Chan, Vishit Patel, Maryam A Adas, Fabiola Atzeni, Kenrick K H Ng, Andrew I Rutherford, Sam Norton, Andrew P Cope, James B Galloway
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications. Annals of the rheumatic diseases (2023)
Céleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, Rieke E Alten, Katerina Chatzidionysiou, James B Galloway, John Isaac, Denis Mulleman, Patrick Verschueren, Arnold G Vulto, Paco M J Welsing, Lise Verhoef, Alfons A den Broeder
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study. RMD open 9 (1) (2023)
Céleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, Rieke E Alten, Katerina Chatzidionysiou, James B Galloway, John Isaac, Denis Mulleman, Patrick Verschueren, Arnold G Vulto, Paco M J Welsing, Lise Verhoef, Alfons A den Broeder
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study. RMD open 9 (1) (2023)
Céleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, Rieke E Alten, Katerina Chatzidionysiou, James B Galloway, John Isaac, Denis Mulleman, Patrick Verschueren, Arnold G Vulto, Paco M J Welsing, Lise Verhoef, Alfons A den Broeder
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study. RMD open 9 (1) (2023)
Melissa Sweeney, Lewis Carpenter, Savia de Souza, Hema Chaplin, Hsiu Tung, Emma Caton, James B Galloway, Andrew Cope, Mark Yates, Elena Nikiphorou, Katherine Jones
Mental health, quality of life and self-management behaviours: online evaluation of inflammatory arthritis patients over 1 year of COVID-19 lockdowns. Rheumatology advances in practice 8 (1) (2023)
Céleste J T van der Togt, Bart Van den Bemt, Daniel Aletaha, Rieke E Alten, Katerina Chatzidionysiou, James B Galloway, John Isaac, Denis Mulleman, Patrick Verschueren, Arnold G Vulto, Paco M J Welsing, Lise Verhoef, Alfons A den Broeder
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study. RMD open 9 (1) (2023)
Prokriti Mukherji, Maryam A Adas, Benjamin Clarke, James B Galloway, Thomas Mulvey, Sam Norton, Jonathan Turner, Mark D Russell, Heidi Lempp, Shuangyu Li
Changing trends in ethnicity and academic performance: observational cohort data from a UK medical school. BMJ open 12 (12) (2022)
Katie Bechman, Emma S Cook, Nick Dand, Zenas Zee Ngai Yiu, Teresa Tsakok, Freya Meynell, Bolaji Coker, Alexandra Vincent, Herve Bachelez, Ines Barbosa, Matthew A Brown, Francesca Capon, Claudia R Contreras, Claudia De La Cruz, Paola Di Meglio, Paolo Gisondi, Denis Jullien, Jade Kelly, Jo Lydie Wilfried Lambert, Camille Lancelot, Sinéad M Langan, Kayleigh J Mason, Helen McAteer, Lucy Moorhead, Luigi Naldi, Katherine Jones, Lluis L Puig, Phyllis I Spuls, Tiago Torres, Dominic Urmston, Amber Vesty, Richard Bruce Warren, Hoseah Waweru, John Weinman, Christopher Ernest Maitland Griffiths, Jonathan N W N Barker, Catherine H Smith, James B Galloway, Satveer K Mahil, null null
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey. The British journal of dermatology 187 (2) (2022)
George E Fragoulis, Mrinalini Dey, Sizheng Zhao, Jan Schoones, Delphine Sophie Courvoisier, James B Galloway, Kimme L Hyrich, Elena Nikiphorou
Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. RMD open 8 (2) (2022)
George E Fragoulis, Elena Nikiphorou, Mrinalini Dey, Sizheng Steven Zhao, Delphine Sophie Courvoisier, Laurent Arnaud, Fabiola Atzeni, Georg Mn Behrens, Johannes Wj Bijlsma, Peter Böhm, Costas A Constantinou, Silvia Garcia-Diaz, Meliha Crnkic Kapetanovic, Kim Lauper, Mariana S F Luís, Jacques Morel, György Nagy, Eva Poleverino, Jef van Rompay, Marco Sebastiani, Anja Strangfeld, Annette de Thurah, James B Galloway, Kimmie L Hyrich
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Annals of the rheumatic diseases (2022)
Prokriti Mukherji, Maryam A Adas, Benjamin Clarke, James B Galloway, Thomas Mulvey, Sam Norton, Jonathan Turner, Mark D Russell, Heidi Lempp, Shuangyu Li
Changing trends in ethnicity and academic performance: observational cohort data from a UK medical school. BMJ open 12 (12) (2022)
Prokriti Mukherji, Maryam A Adas, Benjamin Clarke, James B Galloway, Thomas Mulvey, Sam Norton, Jonathan Turner, Mark D Russell, Heidi Lempp, Shuangyu Li
Changing trends in ethnicity and academic performance: observational cohort data from a UK medical school. BMJ open 12 (12) (2022)
Mrinalini Dey, Katie Bechman, Sizheng Zhao, George E Fragoulis, Catherine Smith, Andrew Cope, Elena Nikiphorou, Kimme L Hyrich, James B Galloway
Infection profile of immune-modulatory drugs used in autoimmune diseases: analysis of summary of product characteristic data. RMD open 8 (2) (2022)
Prokriti Mukherji, Maryam A Adas, Benjamin Clarke, James B Galloway, Thomas Mulvey, Sam Norton, Jonathan Turner, Mark D Russell, Heidi Lempp, Shuangyu Li
Changing trends in ethnicity and academic performance: observational cohort data from a UK medical school. BMJ open 12 (12) (2022)
Prokriti Mukherji, Maryam A Adas, Benjamin Clarke, James B Galloway, Thomas Mulvey, Sam Norton, Jonathan Turner, Mark D Russell, Heidi Lempp, Shuangyu Li
Changing trends in ethnicity and academic performance: observational cohort data from a UK medical school. BMJ open 12 (12) (2022)
James B Galloway, Fabiola Atzeni
JAK inhibitors: special issue foreword. Expert review of clinical immunology 18 (3) (2022)
Sanketh Rampes, Vishit Patel, Ailsa Bosworth, Clare Jacklin, Deepak Nagra, Mark Yates, Katherine Jones, James B Galloway
Systematic Review and Metaanalysis of the Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis. The Journal of rheumatology 48 (12) (2021)
Katie M White, Alina Ivan, Ruth Williams, James B Galloway, Katherine Jones, Faith Matcham
Remote Measurement in Rheumatoid Arthritis: Qualitative Analysis of Patient Perspectives. JMIR formative research 5 (3) (2021)
Magdalena Zasada, Mark Yates, Nicola Ayers, Zoë Ide, Katherine Jones, James B Galloway, Cath Taylor
Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and Wales. RMD open 7 (3) (2021)
Tasanee Braithwaite, Nicola Jaime Adderley, Anuradhaa Subramanian, James B Galloway, John H Kempen, Krishna Margadhamane Gokhale, Andrew P Cope, Andrew D Dick, Krishnarajah Nirantharakumar, Alastair Keith Denniston
Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease. Arthritis & rheumatology (Hoboken, N.J.) 73 (7) (2021)
Rebecca Francesca D'Cruz, Michael D Waller, Felicity Perrin, Jimstan Periselneris, Katherine Jones, Laura-Jane E Smith, Tanya Patrick, David Walder, Amadea Heitmann, Kai Lee, Rajiv Madula, William McNulty, Patricia Macedo, Rebecca Lyall, Geoffrey Warwick, James B Galloway, Surinder Singh Birringer, Amit Patel, Irem Patel, Caroline J Jolley
Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ open research 7 (1) (2021)
Katie Bechman, Mrinalini Dey, Mark Yates, Marwan Bukhari, Kevin L Winthrop, James B Galloway
The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know. The Journal of rheumatology 48 (8) (2021)
Katie Bechman, Kapil Halai, Mark Yates, Katherine Jones, Andrew P Cope, null null, Kimmie L Hyrich, James B Galloway
Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 73 (10) (2021)
Benedict McDonaugh, Natalia Perepelova, Peter Kellman, James B Galloway, Stefania Rosmini
Recurrent acute pericarditis diagnosed by extra-cellular volume maps. European heart journal (2021)
Maryam A Adas, Edward Alveyn, Emma Cook, Mrinalini Dey, James B Galloway, Katie Bechman
The infection risks of JAK inhibition. Expert review of clinical immunology (2021)
Nicholas G Cunniffe, Simon J Gunter, Michael Brown, Sarah W Burge, Clare Coyle, Anthony De Soyza, Tom Dymond, Hanif Esmail, Darrel P Francis, Jacqui Galloway, James B Galloway, Effrossyni Gkrania-Klotsas, Jane Greenaway, George Katritsis, Prapa Kanagaratnam, Martin D Knolle, Kelly Leonard, Zoe C McIntyre, Ben Prudon, Tommy Rampling, Michelle S Toleman, Ben Warne, Mark Yates, Nicholas J Matheson, Li Su, Sofia Villar, Grant D Stewart, Mark Toshner
How achievable are COVID-19 clinical trial recruitment targets? A UK observational cohort study and trials registry analysis. BMJ open 10 (10) (2020)
Shahida Din, Alexandra J Kent, Richard C G Pollok, Susanna Meade, Nicholas Alexander Kennedy, Ian Arnott, Robert Mark Beattie, Felix Chua, Rachel Cooney, Robin John Dart, James B Galloway, Daniel R Gaya, Subrata Ghosh, Mark J D Griffiths, Laura Hancock, Richard Hansen, Ailsa L Hart, Christopher Andrew Lamb, Charlie W Lees, Jimmy K Limdi, James O Lindsay, Kamal V Patel, Nicholas Powell, Charles D R Murray, Chris S Probert, Timothy Raine, Christian Philipp Selinger, Shaji Sebastian, Philip J Smith, Phillip Tozer, Andrew Ustianowski, Lisa Younge, Mark A Samaan, Peter M Irving
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. Gut 69 (10) (2020)
Fabiola Atzeni, Valeria Nucera, James B Galloway, Szekanecz Zoltán, Mike Nurmohamed
Cardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review. Expert opinion on biological therapy 20 (5) (2019)
Katie Bechman, Mark Yates, Katherine Jones, Andrew P Cope, James B Galloway
Placebo Response in Rheumatoid Arthritis Clinical Trials. The Journal of rheumatology 47 (1) (2019)
Katie Bechman, Lieke Tweehuysen, Toby Garrood, David L Scott, Andrew P Cope, James B Galloway, Margaret H Y Ma
Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes. The Journal of rheumatology 45 (11) (2018)